CTLT

CTLT | Cotação de Ações

Última atualização17/12/2024, 18:00:02

PreçoUS$ 63,48

Variação (dia)-- (0.00%)▼

Min. 52 SemanasUS$ 42,11

Máx. 52 SemanasUS$ 63,50

Capitalização de mercado--

Endereço: 14 Schoolhouse Road, Somerset, NJ, 08873

Telefone: 732 537 6200

Funcionários: 17.000

CTLT

US$ 63,48

17/12/2024 18:00:02

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualUS$ 63,48

Valor de mercado--

Abertura--

Preço máximoUS$ 63,50

Preço mínimoUS$ 63,44

VolumeUS$ 14 mi

Fechamento anteriorUS$ 63,48

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in two segments, Biologics, and Pharma and Consumer Health. The Biologics segment provides formulation, development, and manufacturing for biologic proteins, cell gene, and other nucleic acid therapies; pDNA, iPSCs, oncolytic viruses, and vaccines; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges; and analytical development and testing services for large molecules. The Pharma and Consumer Health segment offers formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations; and oral, nasal, inhaled, and topical dose forms. This segment also provides clinical supply services through manufacturing, packaging, storage, distribution, and inventory management for small-molecule drugs, protein-based biologics, and cell and gene therapies in clinical trials; and pre-clinical screening, formulation, analytical development, and current good manufacturing practices manufacturing at clinical and commercial scale for softgel capsule, Zydis fast-dissolve tablets, oral solid-dose formats, dry powder inhalers, and nasal delivery devices. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions; fill and finish operations for injectable products; and integrated development and product supply chain solutions. It serves biotechnology, pharmaceutical, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was founded in 1933 and is headquartered in Somerset, New Jersey.

Ações relacionadas

IQVIA Holdings Inc.

IQV ▼0.37% | US$ 199,62

Charles River Laboratories International, Inc.

CRL ▲0.21% | US$ 186,50

West Pharmaceutical Services, Inc.

WST ▼0.58% | US$ 332,19

Bio-Rad Laboratories, Inc.

BIO ▲1.09% | US$ 331,62

Teleflex Incorporated

TFX ▲1.01% | US$ 178,27

Busque ativos específicos e obtenha informações detalhadas sobre suas cotações

Utilize a função de busca para encontrar informações detalhadas sobre ativos específicos. Oferecemos dados precisos e atualizados, permitindo que você tome decisões informadas com base nas informações mais recentes do mercado.

Descubra as últimas atualizações do mercado de ações, incluindo os preços de empresas como Magazine Luiza (MGLU3) e Petrobras (PETR4)

Mantenha-se informado sobre o mercado de ações com as atualizações da brapi. Em nossa seção de notícias, fornecemos análises profundas sobre empresas líderes, como Magazine Luiza e Petrobras, auxiliando em decisões de investimento mais esclarecidas.

Saiba mais sobre a brapi e nossa missão de fornecer informações confiáveis

Entenda a missão da brapi em fornecer informações estritamente informativas de fontes confiáveis. Valorizamos a transparência e a responsabilidade, incentivando investidores a buscar aconselhamento financeiro independente para decisões informadas.